Korea's Dong-A Regains Top Spot From Green Cross In Q2 Sales
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Dong-A Pharmaceutical regained South Korea's top sales spot in the second quarter from vaccine maker Green Cross and expects to continue its sales trend through the year